Ophthalmology Times Europe

OTE Articles

Laser shows promise in limiting AMD progressionA proprietary retinal laser technology has demonstrated the potential to reverse the accumulation of drusen in patients with high-risk early AMD over a 24-month period.
Thermodynamic treatment effective for MGDA single thermodynamic treatment can serve as an effective treatment of MGD and the beneficial effects of the treatment can last for 6 months or longer.
Laser-assisted capsulotomy results better than CCCFemtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy.

Advertisement

Aflibercept shows promise in polypoidal choroidal vasculopathyPatients with polypoidal choroidal vasculopathy may benefit from intravitreal aflibercept.
Method helps identify preperimetric glaucomaThe Random Forests machine learning method is a useful tool to help ophthalmologists distinguish between the visual fields (VFs) of individuals with healthy eyes and those with preperimetric open-angle glaucoma (OAG) in which glaucoma will manifest, according to research from Japan.
Fs-laser safe for capsulotomy creationAnterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Advertisement

Trifocal IOLs useful for intermediate visionTwo trifocal IOLs enabled patients to have "a useful third focus for intermediate vision", but also resulted in increased background halos and reduced distance visual quality compared with a multifocal IOL, according to new research.
Nonmydriatic imaging useful in diabetic childrenOphthalmologists may use nonmydriatic retinal imaging to supplement the standard clinical exam to screen diabetic children aged as young as 2 years, according to newly published research.
Combination glaucoma drop moves toward approvalA preservative-free IOP-lowering eye drop that is a combination of tafluprost and timolol (Taptiqom, Santen) is seeking national licences in European countries after a positive decentralized procedure and a final assessment report from reference member state Germany, the Federal Institute for Drugs and Medical Devices of Germany, and agreement by concerned member states that the fixed-dose product is approvable.
Study examines link between MS and uveitisThe findings of a new study will enable clinicians to make more accurate diagnoses of multiple sclerosis (MS) and uveitis while giving people a better understanding of their prognoses, according to its authors.

Advertisement

Advertisement